Company: LPSN
Filing Date: 2025-09-17
Form Type: DEF 14A
Source: 0001102993-25-000159
Chunk: 35

Company: LIVEPERSON INC
Filing Date: 2025-09-17
Form: DEF 14A
Chunk 35
---
 the Company’s 2019 Stock Incentive Plan, (ii) 652,670 shares of common stock under the Company’s 2018 Inducement Plan, (iii) 2,439,870 shares of common stock under the Company’s Employee Stock Purchase Plan, (iv) 1,000,000 shares of our common stock subject to a stand-alone stock option award granted to our CEO, (v) 1,848,868 shares of common stock issuable upon exchange of other outstanding options, (vi) 15,551,228 shares issuable upon vesting of outstanding RSUs and performance-vesting RSUs (“PRSUs”), (vii) 14,658,647 shares of common stock issuable upon exercise of outstanding warrants and (viii) 267,527 shares of common stock issuable upon exercise of outstanding 2026 Notes (in each case, prior to giving effect to any change resulting from the Reverse Stock Split). The aggregate number of outstanding and reserved shares of common stock is 187,843,950, prior to giving effect to any change resulting from the Reverse Stock Split.

On September 12, 2025 (the “Closing Date”), the Company consummated a privately negotiated exchange (the “Exchange”) with holders (the “Noteholders”) of approximately $341.1 million aggregate principal amount of our outstanding 0% Convertible Senior Notes due 2026 (the “2026 Notes”) of (x) such 2026 Notes for (y) (i) an aggregate payment of $45.0 million in cash, (ii) $115.0 million in aggregate principal amount of our 10.0% Second Lien Senior Subordinated Secured Notes due 2029, (iii) 53,333,947 shares of common stock (such shares, the “Common Equity Shares”) and (iv) 26,551 shares of Series B Preferred Stock.

The 26,551 shares of Series B Preferred Stock are convertible into 23,217,594 shares of common stock, prior to giving effect to any Reverse Stock Split. We seek authorization for our Board to amend our Charter to increase the number of Authorized Shares of Common Stock by a factor of 1.5x (the “Authorized Common Stock Increase”) to accommodate the conversion of the Series B Preferred Stock. See “Effects of Approving the Authorized Common Stock Increase Proposal” and “Effects of Not Approving the Authorized Common Stock Increase Proposal” below. Our Board